logo

For the Inventor, By the Inventor

Houston, TX, United States of America

Bellicum Pharmaceuticals, Inc.

Calculating rank
USPTO Granted Patents = 9

% Expired Patents = 11.1


Trademarks = 2

Forward Citations = 76

Loading Chart...
Loading Chart...

7 inventors (with patents filed for the assignee):

goldMedal David Spencer (9 out of 27 patents)

silverMedal Aaron Edward Foster (6 out of 7 patents)

bronzeMedal Kevin Slawin (6 out of 15 patents)

4.  Wei-Chun Chang (2 out of 2 patents)

5.  Matthew Robert Collinson-Pautz (1 out of 1 patent)

6.  Natalia Lapteva (1 out of 2 patents)

7.  Dongsu Park (1 out of 1 patent)

8.  Annemarie Moseley (2 patents)

9.  Kevin M Slawin (0 patent)

10.  Matthew R Collinson-pautz (0 patent)

11.  Joseph Henri Bayle (1 patent)

12.  David M Spencer (0 patent)

13.  Mylinh Duong (0 patent)


9 patents:

1. 11839647 - Methods for inducing partial apoptosis using caspase polypeptides (2023-12-12),
2. 10934346 - Modified T cell comprising a polynucleotide encoding an inducible stimulating molecule comprising MyD88, CD40 and FKBP12 (2021-03-02),
3. 10888608 - Costimulation of chimeric antigen receptors by MyD88 and CD40 polypeptides (2021-01-12),
4. 10525110 - Methods for inducing partial apoptosis using caspase polypeptides (2020-01-07),
5. 9944690 - Methods for controlling T cell proliferation (2018-04-17),
6. 9932572 - Modified Caspase polypeptides and uses thereof (2018-04-03),
7. 9913882 - Methods for inducing partial apoptosis using caspase polypeptides (2018-03-13),
8. 9434935 - Modified caspase polypeptides and uses thereof (2016-09-06),
9. 8486693 - Modified dendritic cells having enhanced survival and immunogenicity and related compositions and methods (2013-07-16),
Company Overview
Bellicum Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing novel cellular immunotherapies for various forms of cancer and other serious diseases. Their leading product candidates include BPX-501 and BPX-601, which are designed to improve immune cell therapies by controlling immune reactions and enhancing their efficacy. Bellicum is committed to advancing innovative treatments that have the potential to address unmet medical needs and improve patient outcomes.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

Bellicum Pharmaceuticals, Inc. USPTO Patent Assignee Logo
9 Patents

#515 in Houston, TX

#2,060 in Texas

#32,624 in US

Houston, TX (US)
Houston, TX, United States of America

Bellicum Pharmaceuticals, Inc.

Forward Citations = 76

7 inventors:

goldMedal David Spencer (9 out of 27 patents)

silverMedal Aaron Edward Foster (6 out of 7 patents)

bronzeMedal Kevin Slawin (6 out of 15 patents)

4.  Wei-Chun Chang (2 out of 2 patents)

5.  Matthew Robert Collinson-Pautz (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Bellicum Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/bellicum-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…